Skip to main content


The common theme of departmental research programs is molecular medicine:  that is, the elucidation of the pathogenesis of disease at the molecular level and the application of this knowledge to the design and implementation of novel therapies.  Our established programs include cancer biology, vascular biology, genetics, molecular hemostasis, amyloidogenesis and cholesterol metabolism.  Through collaborations with the Queen’s Cancer Research Institute we also have an emerging strength in translational research.


Researchers with Labs

David Berman, MD, PhD Biomarkers and therapeutic targets for bladder and prostate cancer

Scott Davey, PhD  Basic and translational studies of the DNA damage response

Peter Greer, PhD  Identification and validation of novel therapeutic targets in breast cancer

Harriet Feilotter, PhD, FCCMG  Biomarkers to be used in the screening, diagnosis or treatment of huan diseases, including cancer


Paula James, MD Molecular hemostasis

David LeBrun, MD Molecular mechanisms of leukemogenesis

David Lillicrap, MD Molecular hemostasis


Lois Mulligan, PhD Role of the RET proto-oncogene in cancer

Christopher Nicol, PhD  Cell specific roles of PPARs in breast cancer


Anna Panchenko, PhD  Molecular mechanisms of cancer: detecting drivers with computational and hybrid approaches

Michael Rauh, MD, PhD Translational studies in myeloid blood cancers and innate immune tolerance

Neil Renwick, MD, PhD Translational RNA Biology

Xiaolong Yang, PhD  The molecular and cellular function of tumor suppressors in human cancer


More Researchers with labs coming soon!

Tricia Cottrell, MD, PhD


Page Last Updated: 2023 August 25